CYTOGUIDE
Cytoguide is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and registered drugs with known pharmacological effects to targeting receptor-binding protein partners. The development of receptor-targeted therapeutics will focus on the macrophage specific receptor CD163, the most abundant transport receptor on macrophages. The company has the IP right for existing CD163 targeting technology as well as strong scientific experience and know-how to exploit the use of this receptor for drug therapy. The combined drugs are aimed to improve the treatment of monocyte/macrophage-related diseases including autoimmune disease, leukemia and infectious diseases.
CYTOGUIDE
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Århus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.cytoguide.dk
Status:
Active
Contact:
45 28 99 22 82
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Facebook Sharer ASP.NET IIS Sectigo SSL Sectigo Domain SSL Pinterest
Similar Organizations
Chronos Therapeutics
Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.
IcanoMAB
IcanoMAB is a biotech company focusing on pre-clinical and clinical development for the treatment of cancer and other related diseases.
Current Employees Featured
Founder
Investors List
Lund University Bioscience
Lund University Bioscience investment in Funding Round - Cytoguide
